Invention Grant
US09255096B1 Substituted 1,2,3,4-tetrahydrobenzo[C][2,7] naphthyridines and derivatives thereof as kinase inhibitors
有权
取代的1,2,3,4-四氢苯并[C] [2,7]萘啶及其衍生物作为激酶抑制剂
![Substituted 1,2,3,4-tetrahydrobenzo[C][2,7] naphthyridines and derivatives thereof as kinase inhibitors](/docs/US/2016-02-09/US09255096B1/abs.jpg.600x600.jpg)
- Patent Title: Substituted 1,2,3,4-tetrahydrobenzo[C][2,7] naphthyridines and derivatives thereof as kinase inhibitors
- Patent Title (中): 取代的1,2,3,4-四氢苯并[C] [2,7]萘啶及其衍生物作为激酶抑制剂
-
Application No.: US14508982Application Date: 2014-10-07
-
Publication No.: US09255096B1Publication Date: 2016-02-09
- Inventor: Clarence Eugene Hull, III , Thomas C. Malone
- Applicant: Allergan, Inc.
- Applicant Address: US CA Irvine
- Assignee: Allergan, Inc.
- Current Assignee: Allergan, Inc.
- Current Assignee Address: US CA Irvine
- Agent Jonathan Bass
- Main IPC: C07D471/00
- IPC: C07D471/00 ; C07D491/00 ; C07D471/04
![Substituted 1,2,3,4-tetrahydrobenzo[C][2,7] naphthyridines and derivatives thereof as kinase inhibitors](/abs-image/US/2016/02/09/US09255096B1/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
Information query
